HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclin E overexpression in transitional cell carcinoma of the bladder.

Abstract
We attempted to clarify the relationship between cyclin E to p27(Kip1), Ki-67 and clinicopathologic features in transitional cell bladder carcinoma. Immunohistochemical staining of archival tissue specimens of transitional cell bladder carcinoma obtained from 94 patients was performed by the labeled streptavidin-biotin-peroxidase method. Overexpression of cyclin E protein was observed in 38 of the 94 (40.4%) specimens, and was positively correlated with histological grade, Ki-67 LI and p27(Kip1) labeling index (LI). These data suggest that cyclin E may be associated with aggressive tumor growth, and may have a relationship with p27(Kip1) for the regulation of cell cycle progression in transitional cell bladder carcinoma.
AuthorsK Makiyama, M Masuda, Y Takano, M Iki, T Asakura, Y Suwa, S Noguchi, M Hosaka
JournalCancer letters (Cancer Lett) Vol. 151 Issue 2 Pg. 193-8 (Apr 14 2000) ISSN: 0304-3835 [Print] Ireland
PMID10738114 (Publication Type: Journal Article)
Chemical References
  • Cell Cycle Proteins
  • Cyclin E
  • Ki-67 Antigen
  • Microtubule-Associated Proteins
  • Tumor Suppressor Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
Topics
  • Carcinoma, Transitional Cell (chemistry, pathology)
  • Cell Cycle Proteins
  • Cyclin E (analysis)
  • Cyclin-Dependent Kinase Inhibitor p27
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen (analysis)
  • Microtubule-Associated Proteins (analysis)
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Tumor Suppressor Proteins
  • Urinary Bladder Neoplasms (chemistry, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: